Salmon, Hélène
Remark, Romain
Gnjatic, Sacha
Merad, Miriam
Article History
First Online: 12 March 2019
Competing interests
: H.S. receives research funding from Takeda and Genentech. R.R. is an employee of Innate Pharma. S.G. reports consultancy and/or advisory roles for Merck, Neon Therapeutics and OncoMed and research funding from Bristol-Myers Squibb, Genentech, Immune Design, Agenus, Janssen R&D and Pfizer. M.M. receives funding from Regeneron, Takeda, Genentech and Boehringer Ingelheim.